Are Antacids Necessary as Routine Prescriptives with Non-steroidal Anti-inflammatory Drugs?

Annals of the Academy of Medicine Singapore

Volumn 27, Issue 2, 1998, Pages 219-222

  See, Y ^a   Ng, S C ^b   Tho, K S ^c   Teo, S K ^b  

^a KK WOMEN'S AND CHILDREN'S HOSPITAL   (Singapore)

^b Department of Medicine ^*

^c Royal Alexandra Hospital   (New Zealand)

Author keywords

Cytoprotection; Gastropathy; Short course; Symptoms

Indexed keywords

ANTACID AGENT; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; DRUG EFFICACY; DRUG INDICATION; DRUG USE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PROSPECTIVE STUDY; SINGAPORE;

EID: 0031776746     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Hawkey C J. Non-steroidal anti-inflammatory drug gastropathy: causes and treatment. Scand J Gastroenterol 1996; 220.124-7.
2. Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from non-aspirin non-steroidal anti-inflammatory drugs. Gastroenterology 1993; 105:1078-88.
3. Garcia Rodriguez L A, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343:769-72.
4. . Griffin M R, Piper J M, Daugherty J R, Snowden M, Ray W A Non-steroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114:257-63.
5. Fries J. Toward an understanding of NSAID-related adverse events: The contribution of longitudinal data. Scand J Rheumatol 1996, 25(suppl 102):3-8.
6. Blower A L. Considerations for non-steroidal anti-inflammatory drug therapy: Safety. Scand J Rheumatol 1996, 25(suppl 105):13-26.
7. Walsh J H. Unanswered questions about Helicobacter pylori. Ailment Pharmacol Ther 1995; 9( suppl 1):31-7.
8. Committee on Safety of Medicines. Relative safety of oral non-aspirin NSAIDs Curr Probl Pharmacovig 1994; 20:11.
9. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to the use of non-steroidal anti-inflammatory drugs: a meta-analysis. Ann Intern Med 1991; 115:787-96.
10. . Langman M J, Weil J, Wainwright P, Lawson D H, Rawlins M D, Logan R F, et al Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343-8908, 1075-8.
11. Hoftiezer J W, O'Laughlin J C, Ivey K J. Effects of 24 hours of aspirin, bufferin, paracetomol and placebo on normal human gastroduodenal mucosa. Gut 1982; 23:692-7.
12. Kingston D J, Ito S. Effect of aspirin and related compounds on the fine structure of mouse gastric mucosa. Gastroenterology 1971; 61:156-77
13. Graham D Y, Smith J L. Aspirin and the stomach. Ann Intern Med 1986; 104:390-8.
14. Roth S, Agrawal N, Manowald F, Swabb E, Montaya H, Robbins D, et al. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin. Arch Intern Med 1989; 149:775-9
15. Vane J R Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971; 231:232-5.
16. Appleton I, Tomlinson A, Willoughby D A Inducible cyclooxygenase (COX-2) : a safer therapeutic agent ? Br J Rheumatol 1994; 33:410-2.
17. Mitchell J A, Akarasereenont P, Thiemermann C, Flower R J, Vane J R. Selectivity of non-steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1994; 90:11693-7.
18. Fromm D. Mechanisms involved in gastric mucosal resistance to injury. Ann Rev Med 1987; 38:119-28.
19. Miller TA. Protective effects of prostaglandins against gastric mucosl damage: current knowledge and proposed mechanisms Am J Physiol 1983; 245.G601-23.
20. Cohen M M. Role of endogenous prostaglandins in gastric secretion and mucosal defence. Clin Invest Med 1987; 10.226-31.
21. Werberg R, Berstad K, Berstad A. Acute effects of antacids on gastric juice components in duodenal ulcer patients. Eur Clin Invest 1990; 20:511-5.
22. Carpio R Clinical efficacy of low-dose antacids in treatment of peptic ulcers. Drug Investigation 1990; (suppl 1):18-21.
23. Miller J P. Maintenance of duodenal ulcer healing by antacids. Scand J Gastroenterol Suppl 1990; 174:54-9.
24. Bianchi-Porro G, Parente F. Antacids for duodenal ulcer, current role. Scan J Gastroenterol Suppl 1990; 174:48-53.
25. Nauert C, Caspary W F. Duodenal ulcer therapy with low dose antacids: a multicentre trial. J Clin Gastroenterol 1991; 12 (suppl 1):S149-54.
26. Zaterka S, Cordeiro F, Lyra L G, Toletino M M, Miszputen S J, Jorge J L, et al. Very low dose antacid in treatment of duodenal ulcer. Comparison with cimetidine. Dig Dis Sci 1991; 36 1377-83.
27. Tarnawski A, Hollander D, Gergely H. Antacids: new perspectives in cytoprotection. Scand J Gastroenterol Suppl 1990; 174:9-14.
28. Werberg R, Berstad A, Osnes M. Comparison of low-doseantacids, cimetidine and placebo on 24-hour intragastric acidity in healthy volunteers. Dig Dis Sci 1992; 37:1810-4.
29. Gasbarrini G, Andreone P, Baraldini M, Bonvicini F, Cursaro C, Brocchi E. Protection of the upper gastrointestinal mucosa: the role of antacids. Int J Clin Pharmacol Res 1990; 10:173-8.
30. Tarnawski A. Cytoprotective drugs. Focus on antacids. Drug Investigation 1990; 2:1-6.
31. Sievert W, Stern A I, Lambert J R, Peacock T. Low dose antacids and non-steroidal anti-inflammatory drug induced gastropathy in humans. J Clin Gastroenterol 1991; 13 (suppl 1 ):S145-8.
32. Larkai E N, Smith J L, Lidsky M D, Graham D Y. Gastroduodenal mucosa and dyspeptic symptoms n arthritis patients during chronic non-steroidal anti-inflammatory drug use. Am J Gastroenterol 1987; 82:1153-8.
33. Silvoso G R, Ivey K J, Butt J H, Lockard O O, Holt S D, Sisk C, et al Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 1979, 91:517-20.
34. Caruso I, Bianchi Porro G. Gastroscopic evaluation of anti-inflammatory agents. BMJ 1980, 280:6207, 75-8.
35. Shiokawa Y, Nobunaga M, Saito N, Asaki S, Ogawa N. Epidemiology study of upper GI tract lesions induced by NSAIDs. Ryumachi 1991, 31:96-111.
36. . Skander M P, Ryan F P. Non-steroidal anti-inflammatory drugs and painfree peptic ulceration in the elderly. BMJ 1988, 297:833-4.
37. Armstrong C P, Blower A L. Non-steroidal anti-inflammatory drugs and life-threatening complications of peptic ulceration. Gut 1987; 28:527-32.